ArticleFrontiers in oncology2026

Multi-omics analysis identifies stemness-driven molecular subtypes, prognostic signature, epigenetic target APCDD1, and drug candidate Leflunomide in Wilms tumor.

Huifang Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.